Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.10% | 345.40 | 0.0% | $4305.01m | |
| BNTX | BioNTech SE | 1.75% | 297.50 | 0.0% | $826.30m | |
| NVAX | Novavax, Inc. | -1.10% | 133.51 | 79.4% | $750.47m | |
| AMGN | Amgen, Inc. | 0.00% | 208.68 | 1.4% | $526.19m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.00% | 592.15 | 2.7% | $478.99m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 0.00% | 6.21 | 0.7% | $434.10m | |
| GILD | Gilead Sciences, Inc. | -0.66% | 67.28 | 1.0% | $395.23m | |
| CCXI | ChemoCentryx, Inc. | -0.83% | 33.44 | 2.9% | $383.29m | |
| ILMN | Illumina, Inc. | -0.02% | 417.09 | 3.3% | $357.10m | |
| XLRN | Acceleron Pharma, Inc. | 0.00% | 173.78 | 5.3% | $335.39m | |
| OCGN | Ocugen, Inc. | 5.03% | 9.61 | 0.0% | $318.59m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.23% | 184.50 | 1.9% | $274.69m | |
| BIIB | Biogen, Inc. | 0.00% | 271.12 | 1.8% | $271.81m | |
| XENE | Xenon Pharmaceuticals, Inc. | 0.00% | 30.57 | 0.4% | $164.85m | |
| CRSP | CRISPR Therapeutics AG | 0.05% | 95.11 | 0.6% | $159.15m |
Company Profile
Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company is headquartered in Carlsbad, CA.